AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE (ISNTREE ONION NEWPAIR SUNSCREEN)
AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE risk profile, scheduling, and guidance for claims professionals and care workers . Also known as ISNTREE ONION NEWPAIR SUNSCREEN.
AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE (brand names: ISNTREE ONION NEWPAIR SUNSCREEN) is classified as Minimal risk by AllMeds. FDA approved in the United States. Topical sunscreen ingredients with no systemic pharmacological activity or workplace safety implications.
Key Takeaways
- Risk level: Minimal (0 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | Not PBS listed |
| United States (FDA) | Rx only | FDA approved |
Risk Profile
Topical sunscreen ingredients with no systemic pharmacological activity or workplace safety implications.
Regulatory and Compliance Guidance
When AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
United States FDA / CDC / State WC
FDA approved for use in the United States.
Check this medication against your full medication list
Run a full risk assessment including AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.